Gregory Kaufman, MD
Basic profileThe University of Texas MD Anderson Cancer Center
Gregory Kaufman is a Hematology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 58 publications with 747 citations (h-index 12); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 77030
Telephone
713-792-6161Provider last certified this registry record 10 Nov 2020.
Clinical trials
- A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
- Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
- A Study of AA4500 in Men With Peyronie's Disease
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year20241 payment
- Stemline Therapeutics Inc.Program year20241 payment
- SOBI, INCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Age on Autologous Stem Cell Transplantation Outcomes for AL Amyloidosis
Biology of Blood and Marrow Transplantation
2025 - Predictive Factors for Transplant Outcomes of Cardiac AL Amyloidosis
Biology of Blood and Marrow Transplantation
2025 - Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy
Clinical Lymphoma Myeloma & Leukemia
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”